IntelliPharmaCeutics Announces Second Quarter 2010 Results
7/15/2010 11:21:44 AM
More...
|
IntelliPharmaCeutics Provides Update on Activities Related to Venlafaxine Hydrochloride Extended Release Capsules
7/6/2010 11:00:51 AM
More...
|
IntelliPharmaCeutics Files ANDA With the FDA for Generic Protonix(R)
6/14/2010 10:07:49 AM
More...
|
IntelliPharmaCeutics Announces Significant Advance in Its Abuse-Deterrent Oxycodone Program
5/21/2010 10:05:57 AM
More...
|
FDA Accepts for Filing IntelliPharmaCeutics' ANDA for Generic Effexor XR(R)
5/7/2010 9:51:00 AM
More...
|
IntelliPharmaCeutics Announces Approval of Settlement Related to ADHD Drug Focalin XR(R)
5/6/2010 9:39:59 AM
More...
|
IntelliPharmaCeutics Announces First Quarter 2010 Results
4/14/2010 9:19:26 AM
More...
|
IntelliPharmaCeutics Announces Settlement for its Generic Version of Focalin XR(R)
3/12/2010 8:21:43 AM
More...
|
IntelliPharmaCeutics Announces 2009 Eleven Month Period End Results
3/1/2010 8:25:46 AM
More...
|
IntelliPharmaCeutics to Host Conference Call and Webcast on March 1, 2010 at 10:00 a.m. Eastern Time
2/23/2010 9:40:15 AM
More...
|
|